Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valérie Leclair

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Current Opinion in Rheumatology|September 8, 2021
Polymyositis: does it really exist as a distinct clinical subset?Valérie Leclair, Antonella Notarnicola, Jiri Vencovsky, et al.
SAGE Open Medical Case Reports|June 30, 2025
Nailfold capillaroscopy in myositis: A case seriesThaisa Cotton, Marie Hudson, Yves Troyanov, et al.
Thrombosis Journal|February 24, 2026
Lupus anticoagulant hypoprothrombinemia syndrome successfully treated with rituximab - case reportMichael Iarossi, Angelo Rizzolo, Michèle Stanciu, et al.
Rheumatology (Oxford, England)|April 13, 2026
Comment on: Prevalence, distribution and associations of the scleroderma capillaroscopic patterns: new insights from the Italian SPRING-SIR registryHao Cheng Shen, Valérie Leclair, Thaisa Cotton, et al.
Acta Neuropathologica|June 11, 2021
Capillary basement membrane reduplication in myositis patients with mild clinical features of systemic sclerosis supports the concept of 'scleromyositis'Benjamin Ellezam, Valérie Leclair, Yves Troyanov, et al.
Rheumatology (Oxford, England)|January 29, 2019
Efficacy and safety of rituximab in anti-synthetase antibody positive and negative subjects with idiopathic inflammatory myopathy: a registry-based studyValérie Leclair, Angeles Shunashy Galindo-Feria, Maryam Dastmalchi, et al.
Seminars in Arthritis and Rheumatism|August 18, 2021
Distribution and trajectory of direct and indirect costs of idiopathic inflammatory myopathiesValérie Leclair, John Moshtaghi-Svensson, Malin Regardt, et al.
Rheumatology (Oxford, England)|November 8, 2025
Nailfold videocapillaroscopy abnormalities in autoimmune inflammatory myopathy subsetsValérie Leclair, Thaisa Cotton, Hao Cheng Shen, et al.
The Journal of Rheumatology|June 15, 2026
Does the ACR/EULAR Total Improvement Score reflect how individuals with autoimmune inflammatory myopathies feel and function?Valérie Leclair, Claudie Berger, Maude Bouchard-Marmen, et al.
Nature Reviews. Rheumatology|March 22, 2024
Reply to: Current classification criteria underestimate the incidence of idiopathic inflammatory myopathies by ignoring subgroupsThomas Khoo, James B Lilleker, Bernard Yu-Hor Thong, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Current Opinion in Rheumatology|September 8, 2021
Polymyositis: does it really exist as a distinct clinical subset?Valérie Leclair, Antonella Notarnicola, Jiri Vencovsky, et al.
SAGE Open Medical Case Reports|June 30, 2025
Nailfold capillaroscopy in myositis: A case seriesThaisa Cotton, Marie Hudson, Yves Troyanov, et al.
Thrombosis Journal|February 24, 2026
Lupus anticoagulant hypoprothrombinemia syndrome successfully treated with rituximab - case reportMichael Iarossi, Angelo Rizzolo, Michèle Stanciu, et al.
Rheumatology (Oxford, England)|April 13, 2026
Comment on: Prevalence, distribution and associations of the scleroderma capillaroscopic patterns: new insights from the Italian SPRING-SIR registryHao Cheng Shen, Valérie Leclair, Thaisa Cotton, et al.
Acta Neuropathologica|June 11, 2021
Capillary basement membrane reduplication in myositis patients with mild clinical features of systemic sclerosis supports the concept of 'scleromyositis'Benjamin Ellezam, Valérie Leclair, Yves Troyanov, et al.
Rheumatology (Oxford, England)|January 29, 2019
Efficacy and safety of rituximab in anti-synthetase antibody positive and negative subjects with idiopathic inflammatory myopathy: a registry-based studyValérie Leclair, Angeles Shunashy Galindo-Feria, Maryam Dastmalchi, et al.
Seminars in Arthritis and Rheumatism|August 18, 2021
Distribution and trajectory of direct and indirect costs of idiopathic inflammatory myopathiesValérie Leclair, John Moshtaghi-Svensson, Malin Regardt, et al.
Rheumatology (Oxford, England)|November 8, 2025
Nailfold videocapillaroscopy abnormalities in autoimmune inflammatory myopathy subsetsValérie Leclair, Thaisa Cotton, Hao Cheng Shen, et al.
The Journal of Rheumatology|June 15, 2026
Does the ACR/EULAR Total Improvement Score reflect how individuals with autoimmune inflammatory myopathies feel and function?Valérie Leclair, Claudie Berger, Maude Bouchard-Marmen, et al.
Nature Reviews. Rheumatology|March 22, 2024
Reply to: Current classification criteria underestimate the incidence of idiopathic inflammatory myopathies by ignoring subgroupsThomas Khoo, James B Lilleker, Bernard Yu-Hor Thong, et al.
Pageof 4